Global Digital Polymerase Chain Reaction (PCR) Market - Industry Trends and Forecast to 2030
Global Digital Polymerase Chain Reaction (PCR) market is expected to reach USD 13,586.21 million by 2030 from USD 6,149.09 million in 2022, growing at a CAGR of 11.1% during the forecast period of 2023 to 2033.
Market Segmentation
Global Digital Polymerase Chain Reaction (PCR) Market, By Product Type (Digital PCR Instruments, Consumables and Reagents, and Software and Services), Technology (Droplet Digital PCR, Beaming Digital PCR), Application (Clinical, Life Science & Research, and Others), End Users (Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, Diagnostic Laboratories, Academic and Research Organizations, Reference Laboratories and Others), Distribution Channel (Direct Tenders, Retail Sales, Others), Country (U.S., Canada, Mexico, Germany, France, U.K, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Rest of Europe, China, Japan, India ,South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Kuwait, and the Rest of Middle East and Africa) – Industry Trends and Forecast to 2030
Overview of the Global Digital Polymerase Chain Reaction (PCR) Market Dynamics
Drivers
.
• Rise in Availability of Digital PCR Diagnostics
• Increasing Application of Digital PCR
Restraints
• Limitations in Analyzing Novel Complex Devices
• High Cost of Digital PCR Devices
Opportunity
• Rising Product Innovations through Research and Development Activities
Market Players
Some of the major market players operating in the global digital polymerase chain reaction (PCR) market are:
• F. Hoffmann-La Roche Ltd
• Bio-Rad Laboratories Inc.
• Merck KGaA
• Thermo Fisher Scientific Inc.
• QIAGEN
• Eppendorf SE
• Sysmex Corporation
• Stilla
• RainSure Scientific
• Accumax
• Standard BioTools Inc
• JN Medsys
• VSI Electronics Pvt. Ltd
• Precigenome LLC